Eyedentity closes oversubscribed early-stage round led by Norrsken Launcher
What's the deal? EyedentityDealroom has a profile for this one. Try Dealroom →, a Swedish startup in the Karolinska Institutet InnovationDealroom has a profile for this one. Try Dealroom → Incubator, has closed an oversubscribed early-stage round led by Norrsken LauncherDealroom has a profile for this one. Try Dealroom →. Karolinska Institutet Innovation is also investing, alongside other backers.
What's the endgame? The company is building an AI-based diagnostics platform to catch serious eye diseases during routine examinations. Its first application targets uveal melanoma, a rare and potentially fatal eye cancer that is hard to spot early.
Why now? The technology plugs into existing eye-care infrastructure and helps opticians flag cases needing specialist review. Eyedentity is already running a live pilot with SynologenDealroom has a profile for this one. Try Dealroom →, a network of independent Swedish opticians.
The funding will support Eyedentity as it develops its technology and business. The relationship with the lead investor began when the team pitched at Karolinska Institutet Innovation InvestorDay earlier this year.
"We first connected with Norrsken when we pitched at Karolinska Institutet Innovation InvestorDay, and it is great to see how that opportunity developed into an investment," said Mats Holmström, chief executive officer of Eyedentity.
The signal: The round shows how incubators can move science-based startups from lab bench to capital. "The team has developed rapidly during its time in the incubator, made a strong impression at InvestorDay and has now attracted an oversubscribed investment round," said Johan Weigelt, chief executive officer of Karolinska Institutet Innovation.
Read more: Newsmachine
Image credit: Generated with Gemini
